COPD frequently asked questions
This page is specifically for patients who have been prescribed Anoro Ellipta. If you are not a patient please return to the public website.
GSK does not recommend, endorse or accept liability for sites controlled by third-parties.
References:
- Time for a smoke? One cigarette reduces your life by 11 Minutes BMJ 2000; 320 doi: (Published 1 January 2000)
- Anoro Ellipta 55/22mcg patient information leaflet
- http://www.blf.org.uk/Page/Pulmonary-rehab. Date of access: December 2016
- http://www.blf.org.uk/Page/Going-on-holiday-with-a-lung-condition Date of access: December 2016
▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.
By reporting side effects you can help provide more information on the safety of this medicine.
Anoro and Ellipta are registered trademarks of the GlaxoSmithKline group of companies.